Lonza breaks ground on $500M+ Swiss manufacturing facility
Lonza’s major construction project in Switzerland is taking a big step forward.
The Swiss CDMO has broken ground on a fill-finish manufacturing site in the town of Stein, Switzerland, about 20 miles from its headquarters in Basel. The CHF 500 million ($544 million) facility was announced last summer and will be constructed on the same campus as Lonza’s current clinical drug product facility.
In an email to Endpoints News, Peter Droc, the head of product services at Lonza, said the facility is still on track for completion, with operations slated to start in 2026. The facility still intends to manufacture large-scale commercial products. Additionally, Lonza expects to add around 400 full-time positions at the facility by 2026.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.